WASHINGTON — A coalition that includes pharmacy middlemen and insurers has launched a six-figure ad campaign attacking a cornerstone of President Trump’s plan to lower drug prices, declaring it would amount to a “big pharma bailout.”

The ads, launched by the Campaign for Sustainable Rx Pricing, are focused on Trump’s plan to end the rebates that middlemen and insurers negotiate with drug makers in exchange for a drug’s placement on insurance formularies. The ads seize upon the Trump administration’s own admission that the proposal could raise Medicare premiums, given rebates are typically used to make insurance cheaper for patients.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • You must be kidding!!! PCMA must really be getting a ass kicking from the PBM’s! Taking away drug rebates will take hundreds of millions of dollars from the PBM’s, That were really never theirs to begin with!!!
    This is extortion money !! Period!!
    These PBM’s have to be governed!
    Actually the CEO’s need to be incarcerated for defrauding the federal and state (many states)
    Governments !!! Why doesn’t D.O.J see this !!!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy